Navigation Links
CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
Date:6/4/2008

(BPAR, graft loss, and death) and mean percent change in calculated glomerular filtration rate (GFR; Nankivell equation) at 12 months. Safety endpoints were incidences of adverse events and serious adverse events. Non-inferiority for treatment failure was tested. Baseline characteristics did not differ among treatment groups with living donors accounting for approximately 50 percent of grafts. Eighty-two percent received tacrolimus (Tac) and 18 percent cyclosporine (CyA). CNI doses and levels were significantly lower in the reduced level of CNI. CellCept doses were greater in CyA-treated subjects in all groups.

Study Results

After 12 months, treatment failure resulted in 20.6 percent (50/243) in the concentration-controlled CellCept and a reduced level of CNI group, compared to 28.7 percent (68/237) in the concentration-controlled CellCept and the standard level of CNI group, and 26.7 percent (64/240) in the fixed-dose of CellCept and the standard level CNI group.

Five patients (2.1 percent) in the concentration-controlled CellCept and a reduced level of CNI group died; two patients (0.8 percent) died in the concentration-controlled CellCept and the standard level of CNI group; and five patients (2.1 percent) died in the fixed-dose of CellCept and the standard level CNI group.

Groups Patients Graft Loss BPAR Lost to f/u

MMFcc/CNIrl 243 5 (2.1%) 15 (6.2%) 25 (10.3%)

MMFcc/CNIsl 237 4 (1.7%) 23 (9.7%) 23 (9.6%)

MMFfd/CNIrl 240 4 (1.7%) 23 (9.6%) 32 (13.3%)

Note: events are mutually exclusive because only first event counted/patient

Serum creatinine tended to lower at 12 months in the Tac versus CyA treated patients and in the concentration-controlled CellCept and reduced level of CNI group (p=0.08). The stability of renal function over time was greatest in this group as well. Despite higher CellCept doses in the conc
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
2. Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
3. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
4. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
5. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
6. Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
7. Reduced Lung Capacity Accelerates With Diabetes
8. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
9. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
10. Breast Cancer Treatment Is Reduced to One Week
11. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Connectyx Technologies Holding Group Inc. ... formed a distribution partnership with United States Medical ... Supplies, Respiratory Supplies and Medications as well as ... System. ,, Terms of the partnership were not ... "This partnership adds to our growing distribution channel ...
(Date:12/17/2009)... -- Instacare Corp. (OTC Bulletin Board: ISCR) a ... drugs and diagnostics and at home testing products ... and provider of e-health technologies and revolutionary cell ... as part of the preparation of its Fiscal ... two new Directors and has rejected, as unneeded, ...
(Date:12/17/2009)... N.C., Dec. 17 Pharmaceutical Institute today ... GeneEd, Inc., a company specializing in life science ... e-courses, help expand Pharmaceutical Institute,s already extensive library ... is a leading provider of specialized training solutions ... subsidiary of Campbell Alliance. Financial terms of ...
Breaking Medicine Technology:Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 1Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 2Pillar Capital Announces Acquisition of Medico Labs Assets 58778 1Pillar Capital Announces Acquisition of Medico Labs Assets 58778 2Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 1Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 2
(Date:12/17/2009)... following feature is by Devon Herrick, PhD, Senior Fellow ... People often assume they have little control over how ... sickness cannot be scheduled, doctors prescribe treatments and employers ... Americans. However, there are many overlooked ways to trim ... need. ,, Cut your prescription costs: ...
(Date:12/17/2009)... KONG, Dec. 17 /PRNewswire-Asia/ -- China,s leading high-tech,healthcare ... "the,Group"; Stock Code: 801) is pleased to announce ... the period under review, the Group,s two,associate companies ... Exchange and NASDAQ;,its key businesses have been strengthened, ... hospital management operations. , ...
(Date:12/17/2009)... from a recent Thomson Reuters study show that Chinese ... in 1998 to nearly 112,000 in 2008. , ... of the biomedical literature, has evaluated more than 530 ... only 27 Chinese-authored papers were selected in 2004, this ... to be even higher in 2009. , Jane Hunter, ...
(Date:12/17/2009)... ethnic disparities in cancer survival are greatest for ... successfully, including breast and prostate cancer, according to ... School of Public Health and Herbert Irving Comprehensive ... Hospital. Disparities are small or nonexistent for ... treatment options, such as pancreatic and lung cancer. ...
(Date:12/17/2009)... infections , , THURSDAY, Dec. 17 (HealthDay News) -- Some ... flu virus, and researchers say they,ve found a clue ... of the illness appears to be a molecule called ... off germs and disease. Researchers who analyzed levels of ... last summer found the highest levels in the blood ...
Breaking Medicine News(10 mins):Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3Health News:China rapidly catching up in research impact 2Health News:Cancer survival disparities for most minority populations increase as cancers become more treatable 2
... N.C., Dec. 14 Companies competing in a,regulated ... Organizations have come to rely on integrated quality ... effective quality systems,don,t just spontaneously spring up in ... creating and maintaining a quality operation that,functions across ...
... HealthSouth,Corporation (NYSE: HLS ) today announced ... States Department of Justice on behalf of the,Office ... Health and Human,Services (HHS) to resolve issues associated ... The settlement amount of $14.2,million was previously disclosed ...
... a statement,by Linda A. Suydam, D.P.A., president of ... of the U.S. Food and Drug,Administration,s Nonprescription Drugs ... is safe when used according to the label ... multiple clinical trials.,Today, the FDA,s expert panel voted ...
... workers some leeway promotes positive lifestyle changes, study finds ... work environment promotes healthier lifestyle habits for employees, a ... they have flexibility in their work lives have healthier ... are more likely to start some positive lifestyle changes," ...
... 2007 A new review article from the journal ... treat lymphoma, is now becoming used by dermatologists to ... as the standard therapy in treating aggressive lymphomas, the ... reviewed the off-label uses of rituximab in dermatology and ...
... Dec. 14 /PRNewswire-FirstCall/ - Cardiome Pharma Corp.,(NASDAQ: CRME/TSX: COM) ... held on Friday, December 14, 2007 at 2:00pm Eastern,(11:00am ... To access the conference call, please dial 416-340-8010 ... analysts on which,we will respond to questions at the ...
Other Medicine News:Health News:Integrating Quality into Business Systems for High Performance, Complimentary Excerpt Available from Best Practices, LLC 2Health News:HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government 2Health News:Statement from the Consumer Healthcare Products Association on Today's FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose 2Health News:Workplace Flexibility Can Boost Healthy Behaviors 2Health News:Cardiome to Hold Investor Update Call 2Health News:Cardiome to Hold Investor Update Call 3Health News:Cardiome to Hold Investor Update Call 4
... The CARDIA ASD Occluder has been developed ... defects. Introduced through transseptal venous sheaths the ... for the percutaneous closure of ASD's with ... is incorporated into the twelve arm device ...
Stainless steel plain Steinman Pins available in point types A through F....
Round Bevel-Point Pin Sets available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes....
... , 5mm x 30mm x 175mm, 225mm Half Pin , 5mm x 40mm ... , 5mm, Half Pin , Jet-X Bar 5mm Half Pin ... Half Pin , TI 5mm x 40mm, 1.6 Cannulated ... , TiN 5 x 40, 1.6 Cann , TiN ...
Medicine Products: